Abstract |
Based on genome-scale loss-of-function screens we discovered that Topoisomerase III-β (TOP3B), a human topoisomerase that acts on DNA and RNA, is required for yellow fever virus and dengue virus-2 replication. Remarkably, we found that TOP3B is required for efficient replication of all positive-sense-single stranded RNA viruses tested, including SARS-CoV-2. While there are no drugs that specifically inhibit this topoisomerase, we posit that TOP3B is an attractive anti-viral target.
|
Authors | K Reddisiva Prasanth, Minato Hirano, W Samuel Fagg, Eileen T McAnarney, Chao Shan, Xuping Xie, Adam Hage, Colette A Pietzsch, Alexander Bukreyev, Ricardo Rajsbaum, Pei-Yong Shi, Mark T Bedford, Shelton S Bradrick, Vineet Menachery, Mariano A Garcia-Blanco |
Journal | Antiviral research
(Antiviral Res)
Vol. 182
Pg. 104874
(10 2020)
ISSN: 1872-9096 [Electronic] Netherlands |
PMID | 32735900
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved. |
Chemical References |
- TOP3B protein, human
- DNA Topoisomerases, Type I
|
Topics |
- Betacoronavirus
(physiology)
- Cell Line
- DNA Topoisomerases, Type I
(metabolism)
- Dengue Virus
(physiology)
- Ebolavirus
(physiology)
- Gene Knockout Techniques
- Humans
- Influenza A virus
(physiology)
- RNA Viruses
(metabolism)
- SARS-CoV-2
- Virus Replication
(physiology)
- Yellow fever virus
(physiology)
- Zika Virus
(physiology)
|